Previous Section | Index | Home Page |
29 Jun 2009 : Column 88Wcontinued
Norman Lamb: To ask the Secretary of State for Health (1) what estimate he has made of the cost to the public purse to date of the (a) interim and (b) full National Pandemic Flu Service; what original estimate was made of the outturn cost of each service; and what his latest estimate is of the outturn cost; [282168]
(2) on what date his Department first requested Treasury funding for the full National Pandemic Flu Service; and on what date his Department was notified that funding approval had been given. [282169]
Gillian Merron: The costs incurred to date for system development amount to £11 million. The development costs of the interim solution are £1.4 million. The predicted out-turn for 2009-10 was £18 million (excluding £14.8 million of costs that were contingent on a pandemic actually occurring). The out-turn allowing for a possible mobilisation has now been forecast at £33.6 million under the full National Pandemic Flu Service and £31.7 million under the interim solution.
HM Treasury (HMT) were sighted throughout the developmental work for the National Pandemic Flu Service. The Department formally requested approval for funding on 18 November 2008 and this was granted by HMT on 1 December 2008.
Chris Ruane: To ask the Secretary of State for Health what assessment his Department has made of the effectiveness of treatment involving meditation in (a) mental health and (b) other health care. [282764]
Phil Hope: No assessment has been made.
Chris Ruane: To ask the Secretary of State for Health what assessment his Department has made of the effectiveness of meditation techniques in (a) mental health care and (b) other aspects of health care for prisoners. [283101]
Phil Hope: No assessment has been made.
Annette Brooke: To ask the Secretary of State for Health how many people are being prescribed low-dose naltrexone for the treatment of multiple sclerosis on the NHS. [282005]
Mr. Mike O'Brien: The number of patients prescribed particular drugs is not known, nor the purpose for which they are used. In 2008, the Prescription Cost Analysis system indicates there were 900 prescription items dispensed in the community, in England for low dose naltrexone drugs between 1.5mg and 4.5mg. Available data indicate there was no use of low dose naltrexone drugs in hospitals in England.
Mr. Lansley:
To ask the Secretary of State for Health with reference to the TFR3 and PFR3 financial returns submitted to his Department, how much (a) primary
care trusts and (b) other NHS trusts have spent on (i) administrative and clerical staff, (ii) remuneration of chairmen and non-executive directors, (iii) laundry and cleaning equipment, (iv) postage, (v) telephones, (vi) advertising, (vii) electricity, (viii) gas, (ix) other fuel including oil and coal, (x) business rates, (xi) rent, (xii) remuneration of auditors, (xiii) external contract staffing and consultancy services and (xiv) contract hotel services including cleaning and catering contracts in each year since 2003-04. [278488]
Mr. Mike O'Brien: The data requested are provided in the following tables.
Next Section | Index | Home Page |